NCT01389882

Brief Summary

The purpose of this study is to test the hypothesis that neurally adjusted ventilatory assist (NAVA) will allow to lower the ventilator pressure at equivalent fractions of inspiratory oxygen (FiO2) and partial pressure of CO2 of capillary blood in preterm infants in comparison with currently used standard ventilation (synchronized intermittent mandatory ventilation with pressure-support ventilation, SIMV+PSV).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
26

participants targeted

Target at below P25 for phase_2

Timeline
Completed

Started Mar 2011

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2011

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

July 1, 2011

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 8, 2011

Completed
24 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2011

Completed
3 months until next milestone

Results Posted

Study results publicly available

October 28, 2011

Completed
Last Updated

January 9, 2012

Status Verified

January 1, 2012

Enrollment Period

5 months

First QC Date

July 1, 2011

Results QC Date

September 18, 2011

Last Update Submit

January 5, 2012

Conditions

Keywords

mechanical ventilationdiaphragm electrical activitypressure support

Outcome Measures

Primary Outcomes (1)

  • Peak Inspiratory Pressure

    peak inspiratory pressure measured by a ventilator for 4 hours with each ventilator mode

    four hours

Secondary Outcomes (11)

  • Mean Airway Pressure

    four hours

  • Minute Ventilation

    four hours

  • Expiratory Tidal Volume

    four hours

  • Dynamic Compliance

    four hours

  • Work of Breathing

    four hours

  • +6 more secondary outcomes

Study Arms (1)

ventilator assist

EXPERIMENTAL
Procedure: neurally adjusted ventilatory assist (NAVA) ventilator mode

Interventions

Neurally adjusted ventilatory assist (NAVA) utilizes the electrical activity of the diaphragm (EAdi) to trigger and cycle-off breaths, and therefore presents a means of bypassing the ventilator circuit, and the inherent delays with pneumatic triggering. This is a processed signal, which is not artificially influenced by changes in muscle length, chest wall configuration, and/or lung volume. It represents the summation of muscle motor unit recruitment and/or firing rate, and correlates with phrenic nerve activity. In this mode, the amount of support pressure is coupled with the magnitude of the EAdi. The proportion of support pressure to EAdi (NAVA level) is adjustable.

Also known as: Servo-i (Maquet Critical Care AB, Solna, Sweden)
ventilator assist

Eligibility Criteria

AgeUp to 12 Weeks
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • preterm infants mechanically ventilated
  • ventilatory set frequency is under 25
  • with informed consent of their parents

You may not qualify if:

  • major congenital anomalies
  • patients without self respiratory effort
  • use of sedative or anesthetic drugs
  • grade III or IV intraventricular hemorrhage
  • phrenic nerve palsy or insufficiency

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul National University Children's Hospital

Seoul, 110-733, South Korea

Location

MeSH Terms

Conditions

Premature Birth

Interventions

Interactive Ventilatory Support

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Intervention Hierarchy (Ancestors)

Respiration, ArtificialAirway ManagementTherapeuticsRespiratory Therapy

Limitations and Caveats

Two patients were excluded prior to the study and five patients were interrupted the study because of a developed exclusion criterion during the protocol. Because of eliminated participants, the number of subjects analyzed was reduced.

Results Point of Contact

Title
Dr. Juyoung Lee
Organization
Seoul National University Hospital

Study Officials

  • Han Suk Kim, Ph.D

    Seoul National University Hospital

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assist Professor

Study Record Dates

First Submitted

July 1, 2011

First Posted

July 8, 2011

Study Start

March 1, 2011

Primary Completion

August 1, 2011

Study Completion

August 1, 2011

Last Updated

January 9, 2012

Results First Posted

October 28, 2011

Record last verified: 2012-01

Locations